Rex Wan-Hin Hui

Appearances

EFFECT OF EMPAGLIFLOZIN ON LIVER FAT IN METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE PATIENTS WITHOUT DIABETES MELLITUS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Date
May 18, 2024
BACKGROUND: While sodium-glucose cotransporter 2 inhibitors improves cardiovascular and renal outcomes irrespective of diabetes mellitus (DM) status, their effects in metabolic-dysfunction associated steatotic liver disease (MASLD) patients without diabetes mellitus (DM) are unknown…
Presenter
Ka Shing Cheung
Speakers
Ho Yu Ng
Rex Wan-Hin Hui
Lok Ka Lam
Lung Yi Mak
Yuen Chi Ho
Jing Tong Tan
Esther Chan
Wai-Kay Seto
Man-Fung Yuen
Wai Keung Leung
University of Hong Kong Li Ka Shing Faculty of Medicine